VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q80072663  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241120235952.0
008     241120nneanz||abbn n and d
035 ‎‡a  (WKP)Q80072663‏
024 ‎‡a  0000-0001-7574-2162‏ ‎‡2  orcid‏
024 ‎‡a  14824443200‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q80072663‏
100 0 ‎‡a  জেমস ই ক্লার্ক‏ ‎‡9  bn‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  James E. Clark‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  James E Clark‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's A chemical genetic approach reveals that p38alpha MAPK activation by diphosphorylation aggravates myocardial infarction and is prevented by the direct binding of SB203580.‏
670 ‎‡a  Author's A Novel α-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure.‏
670 ‎‡a  Author's Advancements in pressure-volume catheter technology - stress remodelling after infarction.‏
670 ‎‡a  Author's Aged-senescent cells contribute to impaired heart regeneration.‏
670 ‎‡a  Author's Author Correction: Non-Invasive whole-body detection of complement activation using radionuclide imaging in a mouse model of myocardial ischaemia-reperfusion injury.‏
670 ‎‡a  Author's Cardiac hypertrophy in mice expressing unphosphorylatable phospholemman‏
670 ‎‡a  Author's Cardiac myosin-binding protein C: a potential early biomarker of myocardial injury.‏
670 ‎‡a  Author's Cardioprotection by an anti-MASP-2 antibody in a murine model of myocardial infarction‏
670 ‎‡a  Author's Constitutive glycogen synthase kinase-3alpha/beta activity protects against chronic beta-adrenergic remodelling of the heart.‏
670 ‎‡a  Author's Detection of anthracycline-induced cardiotoxicity using perfusion-corrected Tc sestamibi SPECT‏
670 ‎‡a  Author's Epistatic rescue of Nkx2.5 adult cardiac conduction disease phenotypes by prospero-related homeobox protein 1 and HDAC3.‏
670 ‎‡a  Author's Experimental hyperleptinemia in neonatal rats leads to selective leptin responsiveness, hypertension, and altered myocardial function‏
670 ‎‡a  Author's Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse‏
670 ‎‡a  Author's Investigating the potential role of TRPA1 in locomotion and cardiovascular control during hypertension.‏
670 ‎‡a  Author's Loss of Protein Kinase Novel 1 (PKN1) is associated with mild systolic and diastolic contractile dysfunction, increased phospholamban Thr17 phosphorylation, and exacerbated ischaemia-reperfusion injury‏
670 ‎‡a  Author's Mechanism and consequence of the autoactivation of p38α mitogen-activated protein kinase promoted by TAB1‏
670 ‎‡a  Author's Moving in extreme environments: inert gas narcosis and underwater activities.‏
670 ‎‡a  Author's Myocardial stress remodelling after regional infarction is independent of glycogen synthase kinase-3 inactivation.‏
670 ‎‡a  Author's Non-Invasive whole-body detection of complement activation using radionuclide imaging in a mouse model of myocardial ischaemia-reperfusion injury.‏
670 ‎‡a  Author's Overexpression of the transcription factor Hand1 causes predisposition towards arrhythmia in mice.‏
670 ‎‡a  Author's Patent foramen ovale and scuba diving: a practical guide for physicians on when to refer for screening‏
670 ‎‡a  Author's Post-infarction remodeling is independent of mitogen-activated protein kinase kinase 3‏
670 ‎‡a  Author's Post-infarction remodeling is independent of mitogen-activated protein kinase kinase 3 (MKK3)‏
670 ‎‡a  Author's Pravastatin therapy during preeclampsia prevents long-term adverse health effects in mice.‏
670 ‎‡a  Author's Response to role of hyperleptinemia in the regulation of blood pressure and cardiac function‏
670 ‎‡a  Author's Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury.‏
670 ‎‡a  Author's The POU4F2/Brn-3b transcription factor is required for the hypertrophic response to angiotensin II in the heart‏
670 ‎‡a  Author's The TAB1-p38α complex aggravates myocardial injury and can be targeted by small molecules‏
670 ‎‡a  Author's Thymosin β4 facilitates epicardial neovascularization of the injured adult heart‏
670 ‎‡a  Author's Tissue acidosis does not mediate the hypoxia selectivity of [Cu][Cu‏
670 ‎‡a  Author's Tissue acidosis does not mediate the hypoxia selectivity of [Cu][Cu(ATSM)] in the isolated perfused rat heart‏
670 ‎‡a  Author's Trapped platelets activated in ischemia initiate ventricular fibrillation‏
909 ‎‡a  (scopus) 14824443200‏ ‎‡9  1‏
909 ‎‡a  (orcid) 0000000175742162‏ ‎‡9  1‏
919 ‎‡a  glycogensynthasekinase3inactivationisnotrequiredforischemicpreconditioningorpostconditioninginthemouse‏ ‎‡A  Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse‏ ‎‡9  1‏
919 ‎‡a  experimentalhyperleptinemiainneonatalratsleadstoselectiveleptinresponsivenesshypertensionandalteredmyocardialfunction‏ ‎‡A  Experimental hyperleptinemia in neonatal rats leads to selective leptin responsiveness, hypertension, and altered myocardial function‏ ‎‡9  1‏
919 ‎‡a  epistaticrescueofnkx25adultcardiacconductiondiseasephenotypesbyprosperorelatedhomeoboxprotein1andhdac3‏ ‎‡A  Epistatic rescue of Nkx2.5 adult cardiac conduction disease phenotypes by prospero-related homeobox protein 1 and HDAC3.‏ ‎‡9  1‏
919 ‎‡a  detectionofanthracyclineinducedcardiotoxicityusingperfusioncorrectedtcsestamibispect‏ ‎‡A  Detection of anthracycline-induced cardiotoxicity using perfusion-corrected Tc sestamibi SPECT‏ ‎‡9  1‏
919 ‎‡a  constitutiveglycogensynthasekinase3alphabetaactivityprotectsagainstchronicbetaadrenergicremodellingoftheheart‏ ‎‡A  Constitutive glycogen synthase kinase-3alpha/beta activity protects against chronic beta-adrenergic remodelling of the heart.‏ ‎‡9  1‏
919 ‎‡a  cardioprotectionbyanantimasp2antibodyinamurinemodelofmyocardialinfarction‏ ‎‡A  Cardioprotection by an anti-MASP-2 antibody in a murine model of myocardial infarction‏ ‎‡9  1‏
919 ‎‡a  cardiacmyosinbindingprotein100apotentialearlybiomarkerofmyocardialinjury‏ ‎‡A  Cardiac myosin-binding protein C: a potential early biomarker of myocardial injury.‏ ‎‡9  1‏
919 ‎‡a  cardiachypertrophyinmiceexpressingunphosphorylatablephospholemman‏ ‎‡A  Cardiac hypertrophy in mice expressing unphosphorylatable phospholemman‏ ‎‡9  1‏
919 ‎‡a  authorcorrectionnoninvasivewholebodydetectionofcomplementactivationusingradionuclideimaginginamousemodelofmyocardialischaemiareperfusioninjury‏ ‎‡A  Author Correction: Non-Invasive whole-body detection of complement activation using radionuclide imaging in a mouse model of myocardial ischaemia-reperfusion injury.‏ ‎‡9  1‏
919 ‎‡a  agedsenescentcellscontributetoimpairedheartregeneration‏ ‎‡A  Aged-senescent cells contribute to impaired heart regeneration.‏ ‎‡9  1‏
919 ‎‡a  advancementsinpressurevolumecathetertechnologystressremodellingafterinfarction‏ ‎‡A  Advancements in pressure-volume catheter technology - stress remodelling after infarction.‏ ‎‡9  1‏
919 ‎‡a  novelαcalcitoningenerelatedpeptideanalogueprotectsagainstendorgandamageinexperimentalhypertensioncardiachypertrophyandheartfailure‏ ‎‡A  A Novel α-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure.‏ ‎‡9  1‏
919 ‎‡a  chemicalgeneticapproachrevealsthatp38alphamapkactivationbydiphosphorylationaggravatesmyocardialinfarctionandispreventedbythedirectbindingofsb203580‏ ‎‡A  A chemical genetic approach reveals that p38alpha MAPK activation by diphosphorylation aggravates myocardial infarction and is prevented by the direct binding of SB203580.‏ ‎‡9  1‏
919 ‎‡a  movinginextremeenvironmentsinertgasnarcosisandunderwateractivities‏ ‎‡A  Moving in extreme environments: inert gas narcosis and underwater activities.‏ ‎‡9  1‏
919 ‎‡a  myocardialstressremodellingafterregionalinfarctionisindependentofglycogensynthasekinase3inactivation‏ ‎‡A  Myocardial stress remodelling after regional infarction is independent of glycogen synthase kinase-3 inactivation.‏ ‎‡9  1‏
919 ‎‡a  noninvasivewholebodydetectionofcomplementactivationusingradionuclideimaginginamousemodelofmyocardialischaemiareperfusioninjury‏ ‎‡A  Non-Invasive whole-body detection of complement activation using radionuclide imaging in a mouse model of myocardial ischaemia-reperfusion injury.‏ ‎‡9  1‏
919 ‎‡a  overexpressionofthetranscriptionfactorhand1causespredispositiontowardsarrhythmiainmice‏ ‎‡A  Overexpression of the transcription factor Hand1 causes predisposition towards arrhythmia in mice.‏ ‎‡9  1‏
919 ‎‡a  patentforamenovaleandscubadivingapracticalguideforphysiciansonwhentoreferforscreening‏ ‎‡A  Patent foramen ovale and scuba diving: a practical guide for physicians on when to refer for screening‏ ‎‡9  1‏
919 ‎‡a  postinfarctionremodelingisindependentofmitogenactivatedproteinkinasekinase3‏ ‎‡A  Post-infarction remodeling is independent of mitogen-activated protein kinase kinase 3‏ ‎‡9  1‏
919 ‎‡a  postinfarctionremodelingisindependentofmitogenactivatedproteinkinasekinase3mkk3‏ ‎‡A  Post-infarction remodeling is independent of mitogen-activated protein kinase kinase 3 (MKK3)‏ ‎‡9  1‏
919 ‎‡a  pravastatintherapyduringpreeclampsiapreventslongtermadversehealtheffectsinmice‏ ‎‡A  Pravastatin therapy during preeclampsia prevents long-term adverse health effects in mice.‏ ‎‡9  1‏
919 ‎‡a  responsetoroleofhyperleptinemiaintheregulationofbloodpressureandcardiacfunction‏ ‎‡A  Response to role of hyperleptinemia in the regulation of blood pressure and cardiac function‏ ‎‡9  1‏
919 ‎‡a  targetingofmannanbindinglectinassociatedserineprotease2confersprotectionfrommyocardialandgastrointestinalischemiareperfusioninjury‏ ‎‡A  Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury.‏ ‎‡9  1‏
919 ‎‡a  pou4f2brn3btranscriptionfactorisrequiredforthehypertrophicresponsetoangiotensin2intheheart‏ ‎‡A  The POU4F2/Brn-3b transcription factor is required for the hypertrophic response to angiotensin II in the heart‏ ‎‡9  1‏
919 ‎‡a  tab1p38αcomplexaggravatesmyocardialinjuryandcanbetargetedbysmallmolecules‏ ‎‡A  The TAB1-p38α complex aggravates myocardial injury and can be targeted by small molecules‏ ‎‡9  1‏
919 ‎‡a  thymosinβ4facilitatesepicardialneovascularizationoftheinjuredadultheart‏ ‎‡A  Thymosin β4 facilitates epicardial neovascularization of the injured adult heart‏ ‎‡9  1‏
919 ‎‡a  tissueacidosisdoesnotmediatethehypoxiaselectivityofcu‏ ‎‡A  Tissue acidosis does not mediate the hypoxia selectivity of [Cu][Cu‏ ‎‡9  1‏
919 ‎‡a  tissueacidosisdoesnotmediatethehypoxiaselectivityofintheisolatedperfusedratheart‏ ‎‡A  Tissue acidosis does not mediate the hypoxia selectivity of [Cu][Cu(ATSM)] in the isolated perfused rat heart‏ ‎‡9  1‏
919 ‎‡a  trappedplateletsactivatedinischemiainitiateventricularfibrillation‏ ‎‡A  Trapped platelets activated in ischemia initiate ventricular fibrillation‏ ‎‡9  1‏
919 ‎‡a  mechanismandconsequenceoftheautoactivationofp38αmitogenactivatedproteinkinasepromotedbytab1‏ ‎‡A  Mechanism and consequence of the autoactivation of p38α mitogen-activated protein kinase promoted by TAB1‏ ‎‡9  1‏
919 ‎‡a  lossofproteinkinasenovel1pkn1isassociatedwithmildsystolicanddiastoliccontractiledysfunctionincreasedphospholambanthr17phosphorylationandexacerbatedischaemiareperfusioninjury‏ ‎‡A  Loss of Protein Kinase Novel 1 (PKN1) is associated with mild systolic and diastolic contractile dysfunction, increased phospholamban Thr17 phosphorylation, and exacerbated ischaemia-reperfusion injury‏ ‎‡9  1‏
919 ‎‡a  investigatingthepotentialroleoftrpa1inlocomotionandcardiovascularcontrolduringhypertension‏ ‎‡A  Investigating the potential role of TRPA1 in locomotion and cardiovascular control during hypertension.‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  ISNI|0000000075767151‏
996 ‎‡2  NUKAT|n 2012169171‏
996 ‎‡2  LC|n 80001348‏
996 ‎‡2  LC|n 90651667‏
996 ‎‡2  LC|n 2005041087‏
996 ‎‡2  N6I|vtls002181989‏
996 ‎‡2  NTA|069041105‏
996 ‎‡2  ISNI|0000000032706527‏
996 ‎‡2  DNB|106484653X‏
996 ‎‡2  NKC|xx0051770‏
996 ‎‡2  LC|n 85064856‏
996 ‎‡2  SUDOC|032592833‏
996 ‎‡2  ISNI|0000000117515180‏
996 ‎‡2  NII|DA07909547‏
996 ‎‡2  PLWABN|9814067811405606‏
996 ‎‡2  LC|n 87144470‏
996 ‎‡2  LC|no2010048669‏
996 ‎‡2  LC|nb2009026631‏
996 ‎‡2  LC|nb2009026630‏
996 ‎‡2  ISNI|0000000024540088‏
996 ‎‡2  PLWABN|9810703112205606‏
996 ‎‡2  NII|DA12448545‏
996 ‎‡2  NUKAT|n 2006110659‏
996 ‎‡2  SUDOC|111333717‏
996 ‎‡2  LC|n 00076682‏
996 ‎‡2  ISNI|0000000355707698‏
996 ‎‡2  BNC|981058614798006706‏
996 ‎‡2  W2Z|12070677‏
996 ‎‡2  ISNI|0000000023264990‏
996 ‎‡2  RERO|A024316897‏
996 ‎‡2  BIBSYS|15021485‏
996 ‎‡2  ISNI|0000000039779585‏
996 ‎‡2  LC|n 2002095841‏
996 ‎‡2  JPG|500023714‏
996 ‎‡2  LC|no2015133703‏
996 ‎‡2  J9U|987007297165605171‏
996 ‎‡2  BNF|15050962‏
996 ‎‡2  PLWABN|9810650662405606‏
996 ‎‡2  NTA|071563512‏
996 ‎‡2  ISNI|0000000021792044‏
996 ‎‡2  LC|n 98018276‏
996 ‎‡2  DNB|1158280971‏
996 ‎‡2  LC|n 2021069596‏
996 ‎‡2  NTA|06937113X‏
996 ‎‡2  BNF|14445336‏
996 ‎‡2  BNF|15065910‏
996 ‎‡2  ISNI|0000000451549191‏
996 ‎‡2  NSK|000322852‏
996 ‎‡2  ISNI|0000000029268239‏
996 ‎‡2  LC|no2010083057‏
996 ‎‡2  BIBSYS|90331931‏
996 ‎‡2  DNB|1345834977‏
996 ‎‡2  N6I|vtls002664734‏
996 ‎‡2  PTBNP|1753044‏
996 ‎‡2  LC|n 81120809‏
996 ‎‡2  BIBSYS|4006315‏
996 ‎‡2  CAOONL|ncf10819438‏
996 ‎‡2  LC|no2001046676‏
996 ‎‡2  ISNI|0000000115185085‏
996 ‎‡2  LC|n 2008163483‏
996 ‎‡2  ISNI|0000000109835694‏
996 ‎‡2  NLA|000035028613‏
996 ‎‡2  NLA|000035028612‏
996 ‎‡2  LIH|LNB:B_x_8_n_;=CA‏
996 ‎‡2  PLWABN|9810545402605606‏
996 ‎‡2  LC|n 98103209‏
996 ‎‡2  LNB|LNC10-000033253‏
996 ‎‡2  ISNI|0000000456451572‏
996 ‎‡2  SUDOC|071031359‏
996 ‎‡2  LC|no2015066017‏
996 ‎‡2  NTA|311776353‏
996 ‎‡2  LC|n 85079403‏
996 ‎‡2  LC|n 84804653‏
996 ‎‡2  BNF|14589547‏
996 ‎‡2  SUDOC|102535973‏
996 ‎‡2  JPG|500074822‏
996 ‎‡2  ISNI|0000000049675616‏
996 ‎‡2  LC|no2017050112‏
996 ‎‡2  BIBSYS|90911922‏
996 ‎‡2  LIH|LNB:B_i_A6;=BI‏
996 ‎‡2  LC|nb2014018912‏
996 ‎‡2  LC|n 2018037709‏
996 ‎‡2  BIBSYS|90226705‏
996 ‎‡2  NII|DA09382427‏
996 ‎‡2  ISNI|0000000042151246‏
996 ‎‡2  LC|n 79059935‏
996 ‎‡2  NUKAT|n 2010126413‏
996 ‎‡2  NTA|148393233‏
996 ‎‡2  ISNI|0000000049179647‏
996 ‎‡2  LIH|LNB:C_b____g_;=B_m_‏
996 ‎‡2  SUDOC|194927849‏
996 ‎‡2  ISNI|0000000498315579‏
996 ‎‡2  CAOONL|ncf10819437‏
996 ‎‡2  ISNI|0000000032900979‏
996 ‎‡2  J9U|987007333511905171‏
996 ‎‡2  LC|nb2016001714‏
996 ‎‡2  BAV|495_184468‏
996 ‎‡2  PLWABN|9810580168605606‏
996 ‎‡2  BAV|495_184466‏
996 ‎‡2  BIBSYS|1498562804954‏
996 ‎‡2  DNB|101452718X‏
996 ‎‡2  BIBSYS|90310902‏
996 ‎‡2  RERO|A027289867‏
996 ‎‡2  ISNI|0000000500968932‏
996 ‎‡2  SUDOC|257250956‏
996 ‎‡2  NDL|00805594‏
996 ‎‡2  ISNI|0000000067727408‏
996 ‎‡2  ISNI|0000000388215016‏
996 ‎‡2  LC|n 2011033557‏
996 ‎‡2  SUDOC|150428340‏
996 ‎‡2  ISNI|0000000118218372‏
996 ‎‡2  BNCHL|10000000000000000866731‏
996 ‎‡2  BNF|14526612‏
996 ‎‡2  ISNI|0000000108873314‏
996 ‎‡2  NUKAT|n 2016180309‏
996 ‎‡2  LC|no2024027099‏
996 ‎‡2  NII|DA11513437‏
996 ‎‡2  DNB|1055103007‏
996 ‎‡2  LIH|LNB:B_o_4K;=BW‏
996 ‎‡2  LC|n 2007160202‏
996 ‎‡2  NII|DA1971114X‏
996 ‎‡2  SUDOC|092101062‏
996 ‎‡2  BNC|981061020629706706‏
996 ‎‡2  DNB|117689130‏
996 ‎‡2  NSK|000291755‏
996 ‎‡2  ISNI|0000000418610595‏
996 ‎‡2  LC|no2008172608‏
996 ‎‡2  LC|n 99019820‏
996 ‎‡2  LC|nr2001028118‏
996 ‎‡2  CAOONL|ncf10819439‏
996 ‎‡2  NTA|14981271X‏
996 ‎‡2  SUDOC|242275893‏
996 ‎‡2  ISNI|0000000496320892‏
996 ‎‡2  LC|no 97026353‏
996 ‎‡2  J9U|987007452381005171‏
996 ‎‡2  JPG|500104442‏
996 ‎‡2  LC|no2010206394‏
996 ‎‡2  NTA|265045231‏
996 ‎‡2  BIBSYS|99042394‏
996 ‎‡2  J9U|987007357917205171‏
996 ‎‡2  NLA|000035316617‏
996 ‎‡2  LC|n 86846915‏
996 ‎‡2  BIBSYS|5015839‏
996 ‎‡2  LC|n 85009043‏
996 ‎‡2  LC|n 2005072105‏
996 ‎‡2  LC|no2013118536‏
996 ‎‡2  SUDOC|128889705‏
996 ‎‡2  ISNI|0000000051688707‏
996 ‎‡2  LC|nr 93012901‏
996 ‎‡2  LC|no2020071620‏
996 ‎‡2  LC|nr2004010916‏
996 ‎‡2  ISNI|0000000115615428‏
996 ‎‡2  DNB|114690908X‏
996 ‎‡2  ISNI|0000000041640566‏
996 ‎‡2  DNB|141857773‏
996 ‎‡2  LC|no2019147333‏
996 ‎‡2  ISNI|0000000034130349‏
996 ‎‡2  LC|n 2001035098‏
996 ‎‡2  BIBSYS|90965041‏
996 ‎‡2  CAOONL|ncf10412491‏
996 ‎‡2  ISNI|0000000110271566‏
996 ‎‡2  DNB|1058564005‏
996 ‎‡2  ISNI|0000000067158065‏
996 ‎‡2  DNB|1055332790‏
996 ‎‡2  RERO|A003109262‏
996 ‎‡2  LC|nr2002022598‏
996 ‎‡2  ISNI|0000000045194575‏
996 ‎‡2  ISNI|0000000063767568‏
996 ‎‡2  DNB|173601405‏
996 ‎‡2  J9U|987007437304805171‏
996 ‎‡2  ISNI|0000000048637992‏
996 ‎‡2  NKC|xx0174302‏
996 ‎‡2  LC|n 81098542‏
996 ‎‡2  ISNI|0000000025195300‏
996 ‎‡2  ISNI|0000000052557442‏
996 ‎‡2  ISNI|0000000021508103‏
996 ‎‡2  LC|no 97067396‏
996 ‎‡2  NDL|01133006‏
996 ‎‡2  SUDOC|171344618‏
996 ‎‡2  NUKAT|n 00030514‏
996 ‎‡2  NTA|264819209‏
996 ‎‡2  SUDOC|198092024‏
996 ‎‡2  LC|n 2022023974‏
996 ‎‡2  ISNI|0000000084360716‏
996 ‎‡2  RERO|A022772651‏
996 ‎‡2  JPG|500542805‏
996 ‎‡2  NTA|070367213‏
996 ‎‡2  LC|n 82005721‏
996 ‎‡2  LC|no 97000971‏
996 ‎‡2  NII|DA01559205‏
996 ‎‡2  LC|n 90630299‏
996 ‎‡2  ISNI|0000000385099830‏
996 ‎‡2  ISNI|0000000084545323‏
996 ‎‡2  BIBSYS|90958637‏
996 ‎‡2  ISNI|0000000072683948‏
996 ‎‡2  DNB|1230335412‏
996 ‎‡2  LC|n 82133150‏
996 ‎‡2  LC|no2022130789‏
996 ‎‡2  SUDOC|257834346‏
996 ‎‡2  SUDOC|219553807‏
996 ‎‡2  LC|no 94034692‏
996 ‎‡2  ISNI|0000000052710582‏
996 ‎‡2  ISNI|0000000021702117‏
996 ‎‡2  SUDOC|103557571‏
996 ‎‡2  ISNI|000000007280130X‏
996 ‎‡2  LC|n 2007160242‏
996 ‎‡2  LC|n 84805283‏
996 ‎‡2  SUDOC|127140972‏
996 ‎‡2  NUKAT|n 2015140791‏
996 ‎‡2  LC|no2008049031‏
996 ‎‡2  NKC|hka2012718402‏
996 ‎‡2  LC|n 00036988‏
996 ‎‡2  LC|n 94801710‏
996 ‎‡2  SUDOC|187064539‏
996 ‎‡2  N6I|vtls000031120‏
996 ‎‡2  DNB|1064197434‏
996 ‎‡2  J9U|987007334868205171‏
996 ‎‡2  LNB|LNC10-000006080‏
996 ‎‡2  BIBSYS|90395927‏
996 ‎‡2  ISNI|0000000042006866‏
996 ‎‡2  CAOONL|ncf11163311‏
996 ‎‡2  DNB|1041851669‏
996 ‎‡2  ISNI|0000000042212379‏
996 ‎‡2  RERO|A013641618‏
996 ‎‡2  LC|no2015118733‏
996 ‎‡2  PLWABN|9810536648605606‏
996 ‎‡2  SUDOC|18446403X‏
996 ‎‡2  LC|no2003100631‏
996 ‎‡2  NTA|071947353‏
996 ‎‡2  DNB|107960278X‏
996 ‎‡2  ISNI|0000000035045234‏
996 ‎‡2  LC|n 86017629‏
996 ‎‡2  ISNI|0000000031533484‏
996 ‎‡2  DNB|1056142502‏
996 ‎‡2  LC|no2011082717‏
996 ‎‡2  ISNI|0000000067376185‏
996 ‎‡2  LC|n 2009163582‏
996 ‎‡2  NUKAT|n 2018142633‏
996 ‎‡2  LC|no2021003312‏
996 ‎‡2  LC|n 82060492‏
996 ‎‡2  LC|n 90628579‏
996 ‎‡2  DNB|1183969953‏
996 ‎‡2  BNF|14164941‏
996 ‎‡2  ISNI|0000000119814352‏
996 ‎‡2  BIBSYS|4080090‏
996 ‎‡2  LC|nr2001012720‏
996 ‎‡2  LC|no2012158522‏
996 ‎‡2  NUKAT|n 2015093804‏
996 ‎‡2  DNB|130858595‏
996 ‎‡2  ISNI|0000000035639366‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏